Sponsor Pipeline

Hefei TG ImmunoPharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
8
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05746897 A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients… Ovarian Cancer Recruiting
NCT06374173 A Phase 1 Study to Evaluate TGI-6 in Subjects With Locally Advanced/Metastatic Solid… Advanced or Metastatic Solid Tumors Recruiting
NCT07376707 A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects… CRC (Colorectal Cancer) Recruiting
Disease Areas
Colorectal Cancer (2) Melanoma (2) Breast Cancer (1) Triple-Negative Breast Cancer (1) Ovarian Cancer (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Liver Cancer (1)
Get alerts when Hefei TG ImmunoPharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free